Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report? - AOL
Johnson & Johnson $JNJ Shares Bought by Kera Capital Partners Inc.
PeakShares LLC Makes New $1.11 Million Investment in Johnson & Johnson $JNJ
18,836 Shares in Johnson & Johnson $JNJ Acquired by Independent Financial Group LLC
12,555 Shares in Johnson & Johnson $JNJ Acquired by Forty three Eighteen Advisors LLC
Johnson & Johnson $JNJ Stock Holdings Cut by Bessemer Group Inc.
JNJ Q2 2026 Earnings Report on 7/15/2026
Stronger Guidance, Dividend Steadiness, and FDA Win Might Change The Case For Investing In Johnson & Johnson (JNJ) - Simply Wall St News
The Portfolio That Gives You a $2,000 Raise Every Year
3 Dividend Stocks That Have Survived Every Market Crash in July
Johnson & Johnson (NYSE:JNJ) Stock Rating Upgraded by Freedom Capital - Markets Daily
Journey Advisory Group LLC Reduces Stock Position in Johnson & Johnson $JNJ - Markets Daily
Johnson & Johnson $JNJ Shares Purchased by Wealthfront Advisers LLC
Illinois Municipal Retirement Fund Sells 25,075 Shares of Johnson & Johnson $JNJ
Johnson & Johnson (NYSE:JNJ) Upgraded to "Strong-Buy" at Freedom Capital - Stock Observer
Johnson & Johnson $JNJ Stake Reduced by Geneos Wealth Management Inc.
D.A. Davidson & CO. Sells 50,822 Shares of Johnson & Johnson $JNJ
Wealthfront Advisers LLC Raises Holdings in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Rating Increased to Buy at Wall Street Zen
Beaumont Financial Advisors LLC Has $28.14 Million Stock Position in Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Shares Up 1.2% - Here's What Happened
Johnson & Johnson (JNJ) Stock Faces Margin Squeeze As Q2 Net Profitability Undercuts Bullish Narrative - Simply Wall St News
Johnson & Johnson (NYSE:JNJ) Given Buy Rating at Guggenheim
Eli Lilly (LLY) Is Buying AtaiBeckley To Enter Psychedelic Mental Health Treatments
Medical Stocks To Add to Your Watchlist - July 17th - Daily Political
Hillsdale Investment Management Inc. Reduces Stock Holdings in Johnson & Johnson $JNJ - Zolmax
Johnson & Johnson $JNJ Shares Acquired by MASTERINVEST Kapitalanlage GmbH
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story
Johnson & Johnson $JNJ Shares Acquired by First National Bank of Hutchinson
Harel Insurance Investments & Financial Services Ltd. Purchases 3,481 Shares of Johnson & Johnson $JNJ - Stock Observer
Rep. Thomas H. Kean, Jr. Unloads Shares of Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson (JNJ) To Go Ex-Dividend on August 25th - Daily Political
Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - Stock Observer
Johnson & Johnson $JNJ Shares Bought by Livforsakringsbolaget Skandia Omsesidigt - Daily Political
JNJ: Oncology Focus And New Medicines Will Drive Confidence Through 2026
J&J miss overshadows earnings beat
Johnson & Johnson (JNJ) Crosses $100 Billion As DePuy Synthes Buys Spine Tech - Simply Wall St News
Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.1% Following Earnings Beat - Daily Political
J&J's DePuy Synthes Acquires Expanding Innovations | Morningstar
Bryn Mawr Trust Advisors LLC Has $25.54 Million Holdings in Johnson & Johnson $JNJ - Stock Observer
Calamos Wealth Management LLC Sells 6,096 Shares of Johnson & Johnson $JNJ
Ghe LLC Has $138,000 Stock Holdings in Johnson & Johnson $JNJ
Principal Financial Group Inc. Sells 38,576 Shares of Johnson & Johnson $JNJ - Daily Political
Bleakley Financial Group LLC Boosts Holdings in Johnson & Johnson $JNJ
Calamos Advisors LLC Purchases 122,350 Shares of Johnson & Johnson $JNJ
Johnson & Johnson (NYSE:JNJ) Given Consensus Rating of "Moderate Buy" by Brokerages
Johnson & Johnson $JNJ Shares Acquired by TFR Capital LLC. - Daily Political
Johnson & Johnson $JNJ is Absher Wealth Management LLC's 8th Largest Position - Daily Political
Expert consensus on bedside transcatheter closure of patent ductus arteriosus in extremely low birth weight infants
Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models
Johnson & Johnson Plans Quarterly Dividend of $1.34 (NYSE:JNJ)
Healthcare Stocks Stable Amid Broad Markets Rise - Healthcare Roundup | Morningstar
Johnson & Johnson (NYSE:JNJ) Trading Down 2.5% - Here's What Happened
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
Johnson & Johnson Earnings: Steady Growth and Good Near-Term Visibility | Morningstar
Johnson & Johnson's Oncology, Immunology, and MedTech Leadership Support a Wide Moat | Morningstar
JNJ Stock Pulls Back After Earnings, Setting Up a Buying Opportunity
J&J, Reporting $25B In Q2 sales, Launches Campaign For Psoriasis Pill 07/16/2026
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price
Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King
3 Market-Beating Dividend Kings for Generations of Income
Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner - AOL
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ) - Daily Political
5 Things to Know Before the Stock Market Opens on Wednesday
Johnson & Johnson Lifts FY26 View, Despite Nearly Flat Q2 Profit; Stock Down
Johnson & Johnson Exceeds Q2 Expectations with Strong Pharmaceutical Sales, ETPharma
Vamil Divan: We are looking for accelerating growth into 2027
Dow Jones Top Company Headlines at 7 AM ET: Johnson & Johnson Bumps Up Guidance as Sales Rise | BlackRock ... | Morningstar
Johnson & Johnson (NYSE:JNJ) Releases FY 2026 Earnings Guidance
Johnson & Johnson CFO Joseph Wolk on the company's Q2 results
Johnson & Johnson beats estimates but shares dip
Carnegie Investment Counsel Cuts Stake in Johnson & Johnson $JNJ - Stock Observer
J&J Bumps Up Guidance as 2Q Sales Rise | Morningstar
Johnson & Johnson Bottom Line Declines In Q2
North American Morning Briefing: Stock Futures Rise as Earnings Season Ramps Up | Morningstar
Johnson & Johnson Q2 Earnings Call Highlights - Stock Observer
Promising Medical Stocks To Research - July 15th - Daily Political
Johnson & Johnson (NYSE:JNJ) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - Stock Observer
Triglav Investments D.O.O. Acquires 32,700 Shares of Johnson & Johnson $JNJ
LGT Fund Management Co Ltd. Grows Stake in Johnson & Johnson $JNJ
CORDA Investment Management LLC. Trims Position in Johnson & Johnson $JNJ
Carnegie Investment Counsel Sells 34,449 Shares of Johnson & Johnson $JNJ
ARQ Wealth Advisors LLC Acquires 17,639 Shares of Johnson & Johnson $JNJ
Johnson & Johnson News | Markets Insider
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
